Note that some links may require subscriptions.
To ease a looming shortage of the hypertension drug losartan, the with NMBA (a possible carcinogen) by 10-fold, to 9.82 parts per million, which agency scientists say is safe enough.
The FDA approved solriamfetol (Sunosi) as a treatment for in narcolepsy or obstructive sleep apnea, Jazz Pharmaceuticals announced.
At least three patients in Vancouver died after coatings peeled off certain endovascular devices, leading to -- a problem -- but Health Canada has still done nothing. (Vancouver Sun)
Oh no, not kale! Sorry, but yes -- it's on the of products laden with pesticide residues, along with at least 10 other things you thought were healthy.
A federal judge a Kentucky law that would impose more restrictions on abortion. (ABC News)
And that state's governor said he in place of vaccination. (AP)
Ebola is still . (Reuters)
A Reuters report suggested that China's epidemic on hog farms is worse than officials say.
Among adults in the past 12 months, almost 40% asked their doctor for a cheaper medication, more than 33% didn't take their medication as prescribed, and almost 14% used alternative therapies. (FierceHealthcare)
Is Instagram a viable part of the medical landscape? Medical student Anum Iqbal . (KevinMD)
Roman, the men's health start-up specializing in erectile dysfunction, is . (CNBC)
Screening for pulmonary embolism doesn't have to include CT pulmonary angiography for pregnant women: a can safely rule it out across all trimesters of pregnancy, researchers reported in the New England Journal of Medicine.
Novo Nordisk thinks it has to win U.S. approval. (Reuters)
Morning Break is a daily guide to what's new and interesting on the Web for healthcare professionals, powered by the 鶹ý community. Got a tip? Send it to us: MPT_editorial@everydayhealthinc.com